New applications of cancer immunotherapy

被引：10

作者：

Agarwala, SS ^{[1
]}

机构：

[1] Univ Pittsburgh, Pittsburgh Canc Inst, Melanoma Ctr, Pittsburgh, PA 15213 USA

来源：

SEMINARS IN ONCOLOGY | 2002年 / 29卷 / 03期

关键词：

D O I：

10.1053/sonc.2002.33082

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：1 / 4

页数：4

共 53 条

[31] Interferon alfa-2a and interleukin-2 with or without cisplatin in metastatic melanoma: A randomized trial of the European Organization for Research and Treatment of Cancer Melanoma Cooperative Group [J].

Keilholz, U ;

Goey, SH ;

Punt, CJA ;

Proebstle, TM ;

Salzmann, R ;

Scheibenbogen, C ;

Schadendorf, D ;

Lienard, D ;

Enk, A ;

Dummer, R ;

Hantich, B ;

Geueke, AM ;

Eggermont, AMM .

JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (07) :2579-2588

[32]

KEILHOLZ U, 2000, ANN ONCOL S4, V11

[33] Hydrogen peroxide secreted by tumor-derived macrophages down-modulates signal-transducing zeta molecules and inhibits tumor-specific T cell- and natural killer cell-mediated cytotoxicity [J].

Kono, K ;

SalazarOnfray, F ;

Petersson, M ;

Hansson, J ;

Masucci, G ;

Wasserman, K ;

Nakazawa, T ;

Anderson, P ;

Kiessling, R .

EUROPEAN JOURNAL OF IMMUNOLOGY, 1996, 26 (06) :1308-1313

[34]

Leek RD, 1996, CANCER RES, V56, P4625

[35]

Legha SS, 1996, CANCER, V77, P89, DOI 10.1002/(SICI)1097-0142(19960101)77:1<89::AID-CNCR15>3.3.CO

[36]

2-R

[37]

LEGHA SS, 1986, CANCER, V57, P1675, DOI 10.1002/1097-0142(19860415)57:8+<1675::AID-CNCR2820571307>3.0.CO

[38]

2-I

[39]

MARSONI S, 1987, CANCER TREAT REP, V71, P71

[40]

MASTRANGELO MJ, 1988, SEMIN ONCOL, V15, P589

← 1 2 3 4 5 6 →